title: Skin cancer surveillance and malignancies of the skin in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia.
abstract: OBJECTIVE
  Assess compliance with skin cancer screening guidelines in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia (CLL) and evaluate the clinical utility of such screening.
  
  
  METHODS
  We identified patients diagnosed at Mayo Clinic with CLL between January 1, 2004, and June 1, 2012, who resided within 30 miles of Mayo Clinic. We evaluated adherence to skin cancer screening and identified the prevalence of skin malignancies during follow-up. Medical records were reviewed to document skin cancer screening and diagnosis of a skin malignancy.
  
  
  RESULTS
  Collectively, 113 individuals who met criteria were diagnosed with CLL during the study interval. Forty-one patients (36%) had a whole body skin examination by either a dermatologist or primary care provider documented within 6 months of diagnosis; of these; nine (8% of overall cohort; 22% of examined patients) had a skin malignancy identified. Fifteen additional skin malignancies were diagnosed during follow-up. There were a total of 24 skin malignancies (21% of cohort) diagnosed, including basal cell carcinoma (n = 10), squamous cell carcinoma (n = 11), sebaceous carcinomas (n = 2), and melanoma (n = 1).
  
  
  CONCLUSIONS
  We documented a low compliance with guidelines to screen for skin malignancy in a community-dwelling cohort of patients with newly diagnosed CLL. Standardized and systems-based approaches are likely to increase compliance with skin cancer screening guidelines in patients with CLL.
authors: Mayo Clinic, Rochester, MN.
authors: Aaron S
authors: AS
authors: Mansfield
authors: Kari G
authors: KG
authors: Rabe
authors: Susan L
authors: SL
authors: Slager
authors: Susan M
authors: SM
authors: Schwager
authors: Timothy G
authors: TG
authors: Call
authors: Jerry D
authors: JD
authors: Brewer
authors: Tait D
authors: TD
authors: Shanafelt
mesh_terms: D051997:ADP-ribosyl Cyclase 1 / Q000235:genetics; D000368:Aged; D015331:Cohort Studies; D015897:Comorbidity; D055088:Early Detection of Cancer / Q000379:methods / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D007143:Immunoglobulin Heavy Chains / Q000235:genetics; D007135:Immunoglobulin Variable Region / Q000235:genetics; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D008910:Minnesota / Q000453:epidemiology; D015999:Multivariate Analysis; D016609:Neoplasms, Second Primary / Q000175:diagnosis / Q000453:epidemiology*; D011159:Population Surveillance / Q000379:methods*; D015995:Prevalence; D016016:Proportional Hazards Models; D012307:Risk Factors; D012424:Rural Population / Q000706:statistics & numerical data; D012878:Skin Neoplasms / Q000175:diagnosis / Q000453:epidemiology*; D051746:ZAP-70 Protein-Tyrosine Kinase
chemical_list: D007143:Immunoglobulin Heavy Chains; D007135:Immunoglobulin Variable Region; D051746:ZAP-70 Protein-Tyrosine Kinase; C497261:ZAP70 protein, human; D051997:ADP-ribosyl Cyclase 1
references: Ann Intern Med. 2006 Sep 19;145(6):435-47
references: 16983131
references: Am J Epidemiol. 2011 May 1;173(9):1059-68
references: 21430193
references: CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29
references: 22237781
references: Mayo Clin Proc. 2012 Dec;87(12):1202-13
references: 23199802
references: Crit Rev Oncol Hematol. 2005 Oct;56(1):127-36
references: 15978830
references: Hematology Am Soc Hematol Educ Program. 2007;:324-31
references: 18024647
references: Int J Epidemiol. 2012 Dec;41(6):1614-24
references: 23159830
references: J Clin Oncol. 2012 Mar 10;30(8):843-9
references: 22331952
references: Clin Adv Hematol Oncol. 2012 Sep;10(9):571-6
references: 23073122
references: Mayo Clin Proc. 2004 Mar;79(3):388-98
references: 15008611
references: Mayo Clin Proc. 2012 Feb;87(2):151-60
references: 22305027